
Kardium Stock
Kardium develops medical devices for the diagnosis and treatment of atrial fibrillation.
Sign up today and learn more about Kardium Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Kardium Stock
Kardium is a technology pioneer working to advance medical device technology in the diagnosis and treatment of atrial fibrillation. Kardium was founded in 2007 and has built an outstanding team with a track record of excellence in medicine, business, and engineering. We have hired the best engineers, medical researchers and production staff and have been working with a team of top medical advisors to develop the Globe mapping and ablation system. The Globe system has been entirely developed by the team at Kardium and provides a complete system to assist in the diagnosis and treatment of atrial fibrillation. Kardium is based in Vancouver, Canada, and has consistently ranked as one of the top companies to work for in British Columbia.
Funding History
August 2010 | $868K |
---|---|
April 2014 | $269K |
January 2021 | $115M |
Management
Advisor
John Yeung
Advisor
John Webb
Co-Founder & Advisor
Sam Lichtenstein
CEO
Doug Goertzen
Advisor
Hans Kottkamp
Chairman
Amos Michelson
Advisor
James Abel
Co-Founder & Advisor
Dan Gelbart
Press
TechCrunch - Jun, 11 2014
SourceClear Raises $1.5M Seed Round For Its Software Security Platform | TechCrunchEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase